Search research articles
Contact Us
Filters
Showing results (211-220 of 224) with videos related to
Page
of 23
Sort By:
Annals of Translational Medicine
|
December 24, 2015
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
Jun Guo, Jianhui Ma, Yan Sun, et al.
Thoracic Cancer
|
September 26, 2018
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
Ying Cheng, Yan Wang, Jun Zhao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
May 25, 2017
Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial
Xiang Hu, Lin Chen, Yian Du, et al.
Cell Research
|
June 7, 2017
One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs
Erwei Zuo, Yi-Jun Cai, Kui Li, et al.
Nature Cancer
|
January 5, 2024
Author Correction: Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
Caicun Zhou, Ziping Wang, Meili Sun, et al.
Nature Cancer
|
June 15, 2023
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
Caicun Zhou, Ziping Wang, Meili Sun, et al.
Annals of Translational Medicine
|
January 7, 2016
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)
Jun Guo, Shukui Qin, Jun Liang, et al.
Chinese Clinical Oncology
|
May 12, 2016
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)
Jun Guo, Shukui Qin, Jun Liang, et al.
The Lancet. Oncology
|
June 16, 2025
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial
Caicun Zhou, Ziping Wang, Meili Sun, et al.
Science (New York, N.Y.)
|
June 23, 2022
Pathogen-sugar interactions revealed by universal saturation transfer analysis
Charles J Buchanan, Ben Gaunt, Peter J Harrison, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 224) with videos related to
Sort By:
Page
of 23
Annals of Translational Medicine
|
December 24, 2015
Chinese guidelines on the management of renal cell carcinoma (2015 edition)
Jun Guo, Jianhui Ma, Yan Sun, et al.
Thoracic Cancer
|
September 26, 2018
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
Ying Cheng, Yan Wang, Jun Zhao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
May 25, 2017
Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial
Xiang Hu, Lin Chen, Yian Du, et al.
Cell Research
|
June 7, 2017
One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs
Erwei Zuo, Yi-Jun Cai, Kui Li, et al.
Nature Cancer
|
January 5, 2024
Author Correction: Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
Caicun Zhou, Ziping Wang, Meili Sun, et al.
Nature Cancer
|
June 15, 2023
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
Caicun Zhou, Ziping Wang, Meili Sun, et al.
Annals of Translational Medicine
|
January 7, 2016
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)
Jun Guo, Shukui Qin, Jun Liang, et al.
Chinese Clinical Oncology
|
May 12, 2016
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)
Jun Guo, Shukui Qin, Jun Liang, et al.
The Lancet. Oncology
|
June 16, 2025
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial
Caicun Zhou, Ziping Wang, Meili Sun, et al.
Science (New York, N.Y.)
|
June 23, 2022
Pathogen-sugar interactions revealed by universal saturation transfer analysis
Charles J Buchanan, Ben Gaunt, Peter J Harrison, et al.
Page
of 23